|
Search
Collections
Benchmarks
Upload document
Target
Recurrence Score
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2- breast cancer participating in the GEICAM CARABELA trial.
Org:
Spanish Breast Cancer Group,
Málaga,